These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12594937)

  • 1. Human papillomavirus therapy for the prevention and treatment of cervical cancer.
    Khleif SN
    Curr Treat Options Oncol; 2003 Apr; 4(2):111-9. PubMed ID: 12594937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.
    Daemen T; Pries F; Bungener L; Kraak M; Regts J; Wilschut J
    Gene Ther; 2000 Nov; 7(21):1859-66. PubMed ID: 11110419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer.
    Bosch FX; Muñoz N; de Sanjosé S; Franco EL; Lowy DR; Schiffman M; Franceschi S; Kjaer SK; Meijer CJ; Frazer IH; Cuzick J
    J Natl Cancer Inst; 2001 Sep; 93(17):1349-50. PubMed ID: 11535713
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papillomavirus vaccines for cervical cancer.
    Murakami M; Gurski KJ; Steller MA
    J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital human papillomavirus infection.
    Lowy DR; Kirnbauer R; Schiller JT
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2436-40. PubMed ID: 8146136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer vaccines: progress and prospects.
    Steller MA
    J Soc Gynecol Investig; 2002; 9(5):254-64. PubMed ID: 12383909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus infection and cervical carcinoma.
    Kaufman RH; Adam E; Vonka V
    Clin Obstet Gynecol; 2000 Jun; 43(2):363-80. PubMed ID: 10863634
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
    Zhang L; Zhou F; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.
    Cornelison TL
    Curr Opin Oncol; 2000 Sep; 12(5):466-73. PubMed ID: 10975555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What clinicians should know about human papilloma virus vaccines].
    Sanclemente G
    Gac Med Mex; 2003; 139(2):173-83. PubMed ID: 12754956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
    Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer.
    J Indian Med Assoc; 1997 Feb; 95(2):62-3. PubMed ID: 9357251
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of vaccinology with special reference to papillomavirus vaccines.
    Hilleman MR
    J Clin Virol; 2000 Oct; 19(1-2):79-90. PubMed ID: 11091151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.